SAN DIEGO — Dexcom has announced the upcoming launch of the Dexcom G7 15-Day Continuous Glucose Monitoring (CGM) System for adults aged 18 and older with diabetes. The system will be available in the United States starting December 1. Initially, the Dexcom G7 15-Day will be offered to users who receive their CGM through Durable Medical Equipment (DME) providers. It will also be covered for Medicare beneficiaries, meeting the therapeutic CGM category requirements established by the U.S. Centers for Medicare & Medicaid Services. For individuals aged 2 to 18, the Dexcom G7 continues to be the most accurate continuous glucose monitoring system available.
"We’ve heard loud and clear from our users—they want more time with the Dexcom G7 because it gives them confidence, clarity, and control over their health,” said Grant Ovzinsky, Vice President of Product Management at Dexcom. “With 15.5 days of wear, we’re delivering on that ask. Fewer sensor changes mean less disruption, and more time benefiting from the most accurate CGM. It’s a meaningful step forward in empowering people with diabetes to live life on their terms.”
With an overall MARD of 8.0%, Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range. Available first through DME, the upcoming launch of Dexcom G7 15 Day is a significant advancement in glucose management for people with diabetes, especially those with Medicare coverage.
New with Dexcom G7 15 Day:
- Longest lasting CGM system with 15.5 days of wear.
- Best-in-class accuracy1 with an overall MARD of 8.0%.
- Easier glucose management with fewer monthly sensor changes and reduced monthly waste.
Dexcom G7 features included with Dexcom G7 15 Day:
- The only waterproof CGM available, keeping you more connected.
- Manage diabetes, hands-free. Connect your sensor directly to your Apple Watch so you can leave your iPhone behind and still see your glucose numbers.
- Automated activity logging, simplified meal logging, and new medication logging help you better understand how activity, food, and medications impact your glucose in real time.
- 12-hour grace period to replace finished sensors for a more seamless transition between sessions.
- Innovative and simple mobile app with Dexcom Clarity integration to easily view glucose patterns, trends and statistics via a range of interactive reports.
- Ability to remotely share glucose numbers with caregivers and loved ones for added support and peace of mind.
- Enhanced and customizable alert settings for improved discretion.
“As a disabled veteran living with Type 2 diabetes, becoming a grandfather has given me a powerful new reason to take charge of my health,” said David Padilla, a Dexcom Warrior. “The new Dexcom G7 15 Day CGM System is going to give me, and so many others like me, more time to focus on what really matters while diabetes takes a backseat.”
At launch, Dexcom G7 15 Day will connect with the iLet Bionic Pancreas and Omnipod 5. The company said it is working closely with Tandem and look forward to extending the launch to their customers shortly as they finalize integration. For specific information on pump compatibility and availability with the Dexcom G7 15 Day system, visit Dexcom.com/connectedpumps
